Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy
Carregando...
Citações na Scopus
22
Tipo de produção
article
Data de publicação
2018
Editora
IMPACT JOURNALS LLC
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ONCOTARGET, v.9, n.18, p.14567-14579, 2018
Resumo
Melanoma is a current worldwide problem, as its incidence is increasing. In the last years, several studies have shown that melanoma cells display high levels of autophagy, a self-degradative process that can promote survival leading to drug resistance. Consequently, autophagy regulation represents a challenge for cancer therapy. Herein, we showed that galectin-3 (Gal-3), a β-galactoside binding lectin which is often lost along melanoma progression, is a negative regulator of autophagy in melanoma cells. Our data demonstrated that Gal-3low/negative cells were more resistant to the inhibition of the activity of the cancer driver gene BRAFV600E by vemurafenib (PLX4032). Interestingly, in these cells, starvation caused further LC3-II accumulation in cells exposed to chloroquine, which inhibits the degradative step in autophagy. In addition, Gal-3 low/negative tumor cells accumulated more LC3-II than Gal-3 high tumor cells in vivo. Resistance of Gal-3low/negative cells was associated with increased production of superoxide and activation of the Endoplasmic Reticulum (ER) stress response, as evaluated by accumulation of GRP78. Pharmacological inhibition of autophagy with bafilomycin A reversed the relative resistance of Gal-3low/negative cells to vemurafenib treatment. Taken together, these results show that the autophagic flux is dependent on Gal-3 levels, which attenuate the prosurvival role of autophagy. © Bustos et al.
Palavras-chave
Autophagy, Galectin-3, Melanoma, Starvation, Vemurafenib
Referências
- Cardoso, A.C., Andrade, L.N., Bustos, S.O., Chammas, R., Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments (2016) Front Oncol, 6, p. 127
- Thijssen, V.L., Heusschen, R., Caers, J., Griffioen, A.W., Galectin expression in cancer diagnosis and prognosis: A systematic review (2015) Biochim Biophys Acta, 1855, pp. 235-247
- Ruvolo, P.P., Galectin 3 as a guardian of the tumor microenvironment (2016) Biochim Biophys Acta, 1863, pp. 427-437
- Lepur, A., Carlsson, M.C., Novak, R., Dumic, J., Nilsson, U.J., Leffler, H., Galectin-3 endocytosis by carbohydrate independent and dependent pathways in different macrophage like cell types (2012) Biochim Biophys Acta, 1820, pp. 804-818
- Wang, L., Guo, X.L., Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression (2016) Biomed Pharmacother, 78, pp. 165-171
- Anaka, M., Hudson, C., Lo, P.H., Do, H., Caballero, O.L., Davis, I.D., Dobrovic, A., Behren, A., Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors (2013) BMC Med Genomics, 6, p. 40
- Elder, D.E., Melanoma progression (2016) Pathology, 48, pp. 147-154
- Winder, M., Virós, A., Mechanisms of Drug Resistance in Melanoma (2017) Handb Exp Pharmacol, , Mar 9. [Epub ahead of print]
- Brown, E.R., Doig, T., Anderson, N., Brenn, T., Doherty, V., Xu, Y., Bartlett, J.M., Melton, D.W., Association of galectin-3 expression with melanoma progression and prognosis (2012) Eur J Cancer, 48, pp. 865-874
- Li, Z.W., Wang, Y., Xue, W.C., Si, L., Cui, C.L., Cao, D.F., Zhou, L.X., Lu, A.P., [Expression and prognostic significance of galectin-1 and galectin-3 in benign nevi and melanomas]. [Article in Chinese] (2013) Zhonghua Bing Li Xue Za Zhi, 42, pp. 801-805
- Demirsoy, S., Martin, S., Maes, H., Agostinis, P., Adapt, Recycle, and Move on: Proteostasis and Trafficking Mechanisms in Melanoma (2016) Front Oncol, 6, p. 240
- Amaral, T., Sinnberg, T., Meier, F., Krepler, C., Levesque, M., Niessner, H., Garbe, C., MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibition (2017) Eur J Cancer, 73, pp. 93-101
- Kon, M., Kiffin, R., Koga, H., Chapochnick, J., Macian, F., Varticovski, L., Cuervo, A.M., Chaperone-mediated autophagy is required for tumor growth (2011) Sci Transl Med, 3
- Thorburn, A., Thamm, D.H., Gustafson, D.L., Autophagy and cancer therapy (2014) Mol Pharmacol, 85, pp. 830-838
- White, E., The role for autophagy in cancer (2015) J Clin Invest, 125, pp. 42-46
- Parzych, K.R., Klionsky, D.J., An overview of autophagy: morphology, mechanism, and regulation (2014) Antioxid Redox Signal, 20, pp. 460-473
- Abada, A., Elazar, Z., Getting ready for building: signaling and autophagosome biogenesis (2014) EMBO Rep, 15, pp. 839-852
- Liang, X.H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., Levine, B., Induction of autophagy and inhibition of tumorigenesis by beclin 1 (1999) Nature, 402, pp. 672-676
- Towers, C.G., Thorburn, A., Therapeutic Targeting of Autophagy (2016) EBioMedicine, 14, pp. 15-23
- Lippai, M., Szatmári, Z., Autophagy-from molecular mechanisms to clinical relevance (2017) Cell Biol Toxicol, 33, pp. 145-168
- Mowers, E.E., Sharifi, M.N., Macleod, K.F., Autophagy in cancer metastasis (2017) Oncogene, 36, pp. 1619-1630
- Hara, Y., Nakamura, M., Overexpression of autophagyrelated beclin-1 in advanced malignant melanoma and its low expression in melanoma-in-situ (2012) Eur J Dermatol, 22, pp. 128-129
- Maes, H., Martin, S., Verfaillie, T., Agostinis, P., Dynamic interplay between autophagic flux and Akt during melanoma progression in vitro (2014) Exp Dermatol, 23, pp. 101-106
- Lazova, R., Klump, V., Pawelek, J., Autophagy in cutaneous malignant melanoma (2010) J Cutan Pathol, 37, pp. 256-268
- Corazzari, M., Fimia, G.M., Lovat, P., Piacentini, M., Why is autophagy important for melanoma?. Molecular mechanisms and therapeutic implications (2013) Semin Cancer Biol, 23, pp. 337-343
- Ndoye, A., Weeraratna, A.T., Autophagy-An emerging target for melanoma therapy (2016) F1000Res, 5
- Mourad-Zeidan, A.A., Melnikova, V.O., Wang, H., Raz, A., Bar-Eli, M., Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry (2008) Am J Pathol, 173, pp. 1839-1852
- Wang, Y.G., Kim, S.J., Baek, J.H., Lee, H.W., Jeong, S.Y., Chun, K.H., Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression (2012) Exp Mol Med, 44, pp. 387-393
- Bollag, G., Tsai, J., Zhang, J., Zhang, C., Ibrahim, P., Nolop, K., Hirth, P., Vemurafenib: the first drug approved for BRAFmutant cancer (2012) Nat Rev Drug Discov, 11, pp. 873-886
- Shelledy, L., Roman, D., Vemurafenib: First-in-Class BRAFMutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma (2015) J Adv Pract Oncol, 6, pp. 361-365
- Paz, I., Sachse, M., Dupont, N., Mounier, J., Cederfur, C., Enninga, J., Leffler, H., Sansonetti, P., Galectin-3, a marker for vacuole lysis by invasive pathogens (2010) Cell Microbiol, 12, pp. 530-544
- Lakshminarayan, R., Wunder, C., Becken, U., Howes, M.T., Benzing, C., Arumugam, S., Sales, S., Gaus, K., Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrinindependent carriers (2014) Nat Cell Biol, 16, pp. 595-606
- Thurston, T.L., Wandel, M.P., von Muhlinen, N., Foeglein, A., Randow, F., Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion (2012) Nature, 482, pp. 414-418
- Ma, X.H., Piao, S.F., Dey, S., McAfee, Q., Karakousis, G., Villanueva, J., Hart, L.S., Pawelek, J.M., Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma (2014) J Clin Invest, 124, pp. 1406-1417
- Brauer, M., Amann, M., Burnett, R.T., Cohen, A., Dentener, F., Ezzati, M., Henderson, S.B., Thurston, G.D., Exposure assessment for estimation of the global burden of disease attributable to outdoor air pollution (2012) Environ Sci Technol, 46, pp. 652-660
- Villanueva, J., Vultur, A., Lee, J.T., Somasundaram, R., Fukunaga-Kalabis, M., Cipolla, A.K., Wubbenhorst, B., D'Andrea, K., Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK, IGF-1R/PI3K (2010) Cancer Cell, 18, pp. 683-695
- Tang, D.Y., Ellis, R.A., Lovat, P.E., Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma (2016) Front Oncol, 6, p. 236
- Pankiv, S., Clausen, T.H., Lamark, T., Brech, A., Bruun, J.A., Outzen, H., Øvervatn, A., Johansen, T., p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy (2007) J Biol Chem, 282, pp. 24131-24145
- Rusten, T.E., Stenmark, H., p62, an autophagy hero or culprit? (2010) Nat Cell Biol, 12, pp. 207-209
- Moscat, J., Diaz-Meco, M.T., p62 at the crossroads of autophagy, apoptosis, and cancer (2009) Cell, 137, pp. 1001-1004
- Sahani, M.H., Itakura, E., Mizushima, N., Expression of the autophagy substrate SQSTM1/p62 is restored during prolonged starvation depending on transcriptional upregulation and autophagy-derived amino acids (2014) Autophagy, 10, pp. 431-441
- Chen, X., Khambu, B., Zhang, H., Gao, W., Li, M., Yoshimori, T., Yin, X.M., Autophagy induced by calcium phosphate precipitates targets damaged endosomes (2014) J Biol Chem, 289, pp. 11162-11174
- Fujita, N., Morita, E., Itoh, T., Tanaka, A., Nakaoka, M., Osada, Y., Umemoto, T., Iwai, K., Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin (2013) J Cell Biol, 203, pp. 115-128
- Maejima, I., Takahashi, A., Omori, H., Kimura, T., Takabatake, Y., Saitoh, T., Yamamoto, A., Yoshimori, T., Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury (2013) EMBO J, 32, pp. 2336-2347
- Chauhan, S., Kumar, S., Jain, A., Ponpuak, M., Mudd, M.H., Kimura, T., Choi, S.W., Deretic, V., TRIMs and Galectins Globally Cooperate and TRIM16 and Galectin-3 Co-direct Autophagy in Endomembrane Damage Homeostasis (2016) Dev Cell, 39, pp. 13-27
- Song, L., Tang, J.W., Owusu, L., Sun, M.Z., Wu, J., Zhang, J., Galectin-3 in cancer (2014) Clin Chim Acta, 431, pp. 185-191
- Nabi, I.R., Shankar, J., Dennis, J.W., The galectin lattice at a glance (2015) J Cell Sci, 128, pp. 2213-2219
- Mizushima, N., Autophagy: process and function (2007) Genes Dev, 21, pp. 2861-2873
- Wojtkowiak, J.W., Rothberg, J.M., Kumar, V., Schramm, K.J., Haller, E., Proemsey, J.B., Lloyd, M.C., Gillies, R.J., Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments (2012) Cancer Res, 72, pp. 3938-3947
- Filippi-Chiela, E.C., Bueno e Silva, M.M., Thomé, M.P., Lenz, G., Single-cell analysis challenges the connection between autophagy and senescence induced by DNA damage (2015) Autophagy, 11, pp. 1099-1113
- Wu, S.Y., Lan, S.H., Cheng, D.E., Chen, W.K., Shen, C.H., Lee, Y.R., Zuchini, R., Liu, H.S., Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation (2011) Neoplasia, 13, pp. 1171-1182
- Ito, H., Aoki, H., Kühnel, F., Kondo, Y., Kubicka, S., Wirth, T., Iwado, E., Kondo, S., Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus (2006) J Natl Cancer Inst, 98, pp. 625-636
- Li, L., Tan, J., Miao, Y., Lei, P., Zhang, Q., ROS, Autophagy: Interactions and Molecular Regulatory Mechanisms (2015) Cell Mol Neurobiol, 35, pp. 615-621
- Scherz-Shouval, R., Shvets, E., Elazar, Z., Oxidation as a post-translational modification that regulates autophagy (2007) Autophagy, 3, pp. 371-373
- Chen, Y., Azad, M.B., Gibson, S.B., Superoxide is the major reactive oxygen species regulating autophagy (2009) Cell Death Differ, 16, pp. 1040-1052
- Filomeni, G., De Zio, D., Cecconi, F., Oxidative stress and autophagy: the clash between damage and metabolic needs (2015) Cell Death Differ, 22, pp. 377-388
- Kongara, S., Karantza, V., The interplay between autophagy and ROS in tumorigenesis (2012) Front Oncol, 2, p. 171
- Poillet-Perez, L., Despouy, G., Delage-Mourroux, R., Boyer-Guittaut, M., Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy (2015) Redox Biol, 4, pp. 184-192
- Zhou, W., Xu, G., Wang, Y., Xu, Z., Liu, X., Xu, X., Ren, G., Tian, K., Oxidative stress induced autophagy in cancer associated fibroblast enhances proliferation and metabolism of colorectal cancer cells (2017) Cell Cycle, 16, pp. 73-81
- Zeeshan, H.M., Lee, G.H., Kim, H.R., Chae, H.J., Endoplasmic Reticulum Stress and Associated ROS (2016) Int J Mol Sci, 17, p. 327
- Li, J., Ni, M., Lee, B., Barron, E., Hinton, D.R., Lee, A.S., The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells (2008) Cell Death Differ, 15, pp. 1460-1471
- Bhandary, B., Marahatta, A., Kim, H.R., Chae, H.J., An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases (2012) Int J Mol Sci, 14, pp. 434-456
- Senft, D., Ronai, Z.A., UPR, autophagy, and mitochondria crosstalk underlies the ER stress response (2015) Trends Biochem Sci, 40, pp. 141-148
- Matarrese, P., Tinari, N., Semeraro, M.L., Natoli, C., Iacobelli, S., Malorni, W., Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis (2000) FEBS Lett, 473, pp. 311-315
- Yang, Z.J., Chee, C.E., Huang, S., Sinicrope, F.A., The role of autophagy in cancer: therapeutic implications (2011) Mol Cancer Ther, 10, pp. 1533-1541
- Das, G., Shravage, B.V., Baehrecke, E.H., Regulation and function of autophagy during cell survival and cell death (2012) Cold Spring Harb Perspect Biol, 4
- Elad-Sfadia, G., Haklai, R., Balan, E., Kloog, Y., Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity (2004) J Biol Chem, 279, pp. 34922-34930
- Saegusa, J., Hsu, D.K., Liu, W., Kuwabara, I., Kuwabara, Y., Yu, L., Liu, F.T., Galectin-3 protects keratinocytes from UVB-induced apoptosis by enhancing AKT activation and suppressing ERK activation (2008) J Invest Dermatol, 128, pp. 2403-2411
- Gao, X., Balan, V., Tai, G., Raz, A., Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway (2014) Oncotarget, 5, pp. 2077-2084. , https://doi.org/10.18632/oncotarget.1786
- Seguin, L., Camargo, M.F., Wettersten, H.I., Kato, S., Desgrosellier, J.S., von Schalscha, T., Elliott, K.C., Cheresh, D.A., Galectin-3, a druggable vulnerability for KRAS-addicted cancers (2017) Cancer Discov, 7, pp. 1464-1479
- Martinez-Lopez, N., Athonvarangkul, D., Mishall, P., Sahu, S., Singh, R., Autophagy proteins regulate ERK phosphorylation (2013) Nat Commun, 4, p. 2799
- Grasso, S., Pereira, G.J., Palmeira-Dos-Santos, C., Calgarotto, A.K., Martínez-Lacaci, I., Ferragut, J.A., Smaili, S.S., Bincoletto, C., Autophagy regulates Selumetinib (AZD6244) inducedapoptosis in colorectal cancer cells (2016) Eur J Med Chem, 122, pp. 611-618